Literature DB >> 20651022

Ventricular dilation is associated with improved cardiovascular performance and survival in sepsis.

Sergio L Zanotti Cavazzoni1, Massimiliano Guglielmi, Joseph E Parrillo, Tracy Walker, R Phillip Dellinger, Steven M Hollenberg.   

Abstract

OBJECTIVES: Myocardial dysfunction in sepsis may be associated with changes in left ventricular (LV) size. The goal of this study was to evaluate the impact of myocardial dysfunction and changes in LV diameter on hemodynamics and survival in a murine model of sepsis.
METHODS: C57Bl/6 mice (N = 30) were used. Septic mice (n = 24) had cecal ligation and puncture (CLP) followed by fluid and antibiotic resuscitation and control mice (n = 6) received sham ligation. Echocardiography with a 30-mHz probe was performed at baseline and at frequent predefined time points after CLP. Stroke volume (SV), cardiac output (CO), LV internal diameter in diastole (LVIDd), and fractional shortening (FS) were measured. LV dilation was prospectively defined as an increase in LVIDd ≥ 5% from baseline values. Septic animals were classified as dilators or nondilators.
RESULTS: Among septic animals, 37% were dilators and 63% were nondilators. After CLP, SV and CO decreased early in both groups. With resuscitation, SV and CO improved to a greater extent in dilators than nondilators (for SV, 46.0 ± 8.2 vs 36.1 ± 12.7 μL at 24 h, P = .05; for CO, 20.4 ± 4.8 vs 14.8 ± 6.7 mL/min, P = .04). Survival at 72 h was significantly improved in dilators compared with nondilators (88% vs 40%, P = .01).
CONCLUSIONS: In a clinically relevant murine model of sepsis, animals with LV dilation had better cardiovascular performance and increased survival. Our results suggest that LV dilation is associated with improved SV and CO, a pattern resulting in greatly improved survival. These studies highlight the importance of diastolic function in septic shock.

Entities:  

Mesh:

Year:  2010        PMID: 20651022     DOI: 10.1378/chest.09-1086

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Diastolic dysfunction and mortality in severe sepsis and septic shock.

Authors:  Giora Landesberg; Dan Gilon; Yuval Meroz; Milena Georgieva; Phillip D Levin; Sergey Goodman; Alexander Avidan; Ronen Beeri; Charles Weissman; Allan S Jaffe; Charles L Sprung
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

2.  Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock.

Authors:  Juan N Pulido; Bekele Afessa; Mitsuru Masaki; Toshinori Yuasa; Shane Gillespie; Vitaly Herasevich; Daniel R Brown; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2012-06-08       Impact factor: 7.616

Review 3.  Pathophysiology of sepsis-induced cardiomyopathy.

Authors:  Steven M Hollenberg; Mervyn Singer
Journal:  Nat Rev Cardiol       Date:  2021-01-20       Impact factor: 32.419

4.  The role of speckle tracking echocardiography in assessment of lipopolysaccharide-induced myocardial dysfunction in mice.

Authors:  Ming Chu; Yao Gao; Yanjuan Zhang; Bin Zhou; Bingruo Wu; Jing Yao; Di Xu
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 5.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08

6.  Left ventricular function during porcine-resuscitated septic shock with pre-existing atherosclerosis.

Authors:  Benedikt L Nußbaum; Oscar McCook; Clair Hartmann; José Matallo; Martin Wepler; Elena Antonucci; Miriam Kalbitz; Markus Huber-Lang; Michael Georgieff; Enrico Calzia; Peter Radermacher; Sebastian Hafner
Journal:  Intensive Care Med Exp       Date:  2016-06-06

7.  B-type natriuretic peptide is upregulated by c-Jun N-terminal kinase and contributes to septic hypotension.

Authors:  Matthew Hoffman; Ioannis D Kyriazis; Alexandra Dimitriou; Santosh K Mishra; Walter J Koch; Konstantinos Drosatos
Journal:  JCI Insight       Date:  2020-04-23

Review 8.  Preclinical septic shock research: why we need an animal ICU.

Authors:  Antoine Guillon; Sebastien Preau; Jérôme Aboab; Eric Azabou; Boris Jung; Stein Silva; Julien Textoris; Fabrice Uhel; Dominique Vodovar; Lara Zafrani; Nicolas de Prost; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2019-06-10       Impact factor: 6.925

9.  Myocardial Strain and Cardiac Output are Preferable Measurements for Cardiac Dysfunction and Can Predict Mortality in Septic Mice.

Authors:  Matthew Hoffman; Ioannis D Kyriazis; Anna M Lucchese; Claudio de Lucia; Michela Piedepalumbo; Michael Bauer; P Christian Schulze; Michael J Bonios; Walter J Koch; Konstantinos Drosatos
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

10.  Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor.

Authors:  Areeg I Khan; Sina M Coldewey; Nimesh S A Patel; Mara Rogazzo; Massimo Collino; Muhammed M Yaqoob; Peter Radermacher; Amar Kapoor; Christoph Thiemermann
Journal:  Dis Model Mech       Date:  2013-03-15       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.